Is Appili Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Appili Therapeutics Inc (APLI.TO) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Appili Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Appili Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Appili Therapeutics Inc?

Muslim investors may consider investing in Appili Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Appili Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Appili Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Appili Therapeutics Inc updated?

The Shariah compliance status of Appili Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Appili Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Appili Therapeutics Inc?

You can check the latest Shariah compliance status of Appili Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

APLI.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 16, 2025

Report Source: 2025 Annual Report

Analyst's Ratings for Appili Therapeutics Inc (APLI.TO)

Based on 9 analysts giving stock ratings to Appili Therapeutics Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Appili Therapeutics Inc. Stock Analysis APLI.TO

Canada Health Care Nano Cap Report: 2025 Annual

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. The company is headquartered in Halifax, Nova Scotia. The company went IPO on 2019-06-25. The firm is advancing a diverse range of anti-infectives, including an FDA-approved ready-made suspension of metronidazole for the treatment of antimicrobial-resistant infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease. Its anti-infective product development portfolio includes three programs: LIKMEZ (ATI-1501), ATI-1701, and ATI-1801. ATI-1501 is its advanced commercial stage asset, a liquid oral taste-masked reformulation of the antibiotic metronidazole. ATI-1701 is a novel, live-attenuated vaccine for Francisella tularensis (F. tularensis). ATI-1801 is a novel topical formulation of paromomycin (15% w/w) under advanced clinical development for the treatment of cutaneous leishmaniasis, a disfiguring infection of the skin.

Key Statistics of Appili Therapeutics Inc (APLI.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.02CAD0.02

Today's Open

CAD0.02

Volume

50.00K

P/E Ratio (TTM)

52 Week Range

CAD0.01CAD0.04

Market Cap

2.57M

Avg. Volume

131.98K

Dividend Yield

Financial Metrics & Statements of Appili Therapeutics Inc (APLI.TO)

FAQ's for Appili Therapeutics Inc (APLI.TO)

According to Musaffa’s Shariah screening methodology, Appili Therapeutics Inc (APLI.TO) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.